API-Bioxal, 886 mg/g powder for in-hive use
API-Bioxal, 886 mg/g powder for in-hive use
Authorised
- Oxalic acid
Product identification
Medicine name:
API-Bioxal, 886 mg/g powder for in-hive use
API-Bioxal, 886 mg/g pulveris lietošanai stropā
Active substance:
- Oxalic acid
Target species:
-
Honey bee
Route of administration:
-
In-hive use
Product details
Active substance and strength:
-
Oxalic acid886.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for bee-hive solution
Withdrawal period by route of administration:
-
In-hive use
-
Honey bee
-
Honey0dayDo not use in colonies with supers or during honey flow.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AG03
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Available in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Chemifarma S.p.A.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/21/0019
Date of authorisation status change:
Reference member state:
-
Hungary
Procedure number:
- HU/V/0144/001
Concerned member states:
-
Latvia
-
Slovakia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 15/11/2024
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 15/11/2024